vs

Side-by-side financial comparison of biote Corp. (BTMD) and OneSpan Inc. (OSPN). Click either name above to swap in a different company.

OneSpan Inc. is the larger business by last-quarter revenue ($65.9M vs $46.4M, roughly 1.4× biote Corp.). OneSpan Inc. runs the higher net margin — 17.5% vs 4.2%, a 13.3% gap on every dollar of revenue. On growth, OneSpan Inc. posted the faster year-over-year revenue change (4.1% vs -6.9%). Over the past eight quarters, OneSpan Inc.'s revenue compounded faster (4.0% CAGR vs -0.4%).

biote Corp is a healthcare company specializing in personalized bioidentical hormone replacement therapy solutions for adult men and women. It operates primarily in the U.S. market, offering training programs for licensed healthcare providers, along with complementary wellness supplements and diagnostic services to support patient care outcomes.

OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.

BTMD vs OSPN — Head-to-Head

Bigger by revenue
OSPN
OSPN
1.4× larger
OSPN
$65.9M
$46.4M
BTMD
Growing faster (revenue YoY)
OSPN
OSPN
+10.9% gap
OSPN
4.1%
-6.9%
BTMD
Higher net margin
OSPN
OSPN
13.3% more per $
OSPN
17.5%
4.2%
BTMD
Faster 2-yr revenue CAGR
OSPN
OSPN
Annualised
OSPN
4.0%
-0.4%
BTMD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BTMD
BTMD
OSPN
OSPN
Revenue
$46.4M
$65.9M
Net Profit
$2.0M
$11.6M
Gross Margin
73.6%
Operating Margin
14.7%
22.5%
Net Margin
4.2%
17.5%
Revenue YoY
-6.9%
4.1%
Net Profit YoY
-47.2%
EPS (diluted)
$0.05
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTMD
BTMD
OSPN
OSPN
Q1 26
$65.9M
Q4 25
$46.4M
$62.9M
Q3 25
$48.0M
$57.1M
Q2 25
$48.9M
$59.8M
Q1 25
$49.0M
$63.4M
Q4 24
$49.8M
$61.2M
Q3 24
$51.4M
$56.2M
Q2 24
$49.2M
$60.9M
Net Profit
BTMD
BTMD
OSPN
OSPN
Q1 26
$11.6M
Q4 25
$2.0M
$43.5M
Q3 25
$8.2M
$6.5M
Q2 25
$3.2M
$8.3M
Q1 25
$13.7M
$14.5M
Q4 24
$3.7M
$28.8M
Q3 24
$10.7M
$8.3M
Q2 24
$-7.1M
$6.6M
Gross Margin
BTMD
BTMD
OSPN
OSPN
Q1 26
73.6%
Q4 25
73.6%
Q3 25
73.6%
Q2 25
73.5%
Q1 25
74.3%
Q4 24
74.0%
Q3 24
73.9%
Q2 24
66.2%
Operating Margin
BTMD
BTMD
OSPN
OSPN
Q1 26
22.5%
Q4 25
14.7%
19.9%
Q3 25
17.2%
14.4%
Q2 25
22.0%
17.6%
Q1 25
19.8%
27.1%
Q4 24
5.6%
19.3%
Q3 24
23.7%
20.0%
Q2 24
12.7%
12.5%
Net Margin
BTMD
BTMD
OSPN
OSPN
Q1 26
17.5%
Q4 25
4.2%
69.2%
Q3 25
17.1%
11.4%
Q2 25
6.5%
13.9%
Q1 25
28.0%
22.9%
Q4 24
7.4%
47.1%
Q3 24
20.8%
14.7%
Q2 24
-14.4%
10.8%
EPS (diluted)
BTMD
BTMD
OSPN
OSPN
Q1 26
$0.39
Q4 25
$0.05
$1.13
Q3 25
$0.22
$0.17
Q2 25
$0.10
$0.21
Q1 25
$0.37
$0.37
Q4 24
$0.09
$0.73
Q3 24
$0.33
$0.21
Q2 24
$-0.21
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTMD
BTMD
OSPN
OSPN
Cash + ST InvestmentsLiquidity on hand
$24.1M
$49.8M
Total DebtLower is stronger
$103.1M
Stockholders' EquityBook value
$-58.5M
$272.0M
Total Assets
$107.6M
$383.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTMD
BTMD
OSPN
OSPN
Q1 26
$49.8M
Q4 25
$24.1M
$70.5M
Q3 25
$28.0M
$85.6M
Q2 25
$19.6M
$92.9M
Q1 25
$41.7M
$105.2M
Q4 24
$39.3M
$83.2M
Q3 24
$38.2M
$77.5M
Q2 24
$26.4M
$63.8M
Total Debt
BTMD
BTMD
OSPN
OSPN
Q1 26
Q4 25
$103.1M
Q3 25
$104.7M
Q2 25
$106.3M
Q1 25
$107.8M
Q4 24
$109.4M
Q3 24
$110.9M
Q2 24
$112.5M
Stockholders' Equity
BTMD
BTMD
OSPN
OSPN
Q1 26
$272.0M
Q4 25
$-58.5M
$271.8M
Q3 25
$-72.8M
$238.3M
Q2 25
$-85.1M
$242.5M
Q1 25
$-90.0M
$231.1M
Q4 24
$-105.9M
$212.5M
Q3 24
$-130.3M
$194.6M
Q2 24
$-143.2M
$178.6M
Total Assets
BTMD
BTMD
OSPN
OSPN
Q1 26
$383.1M
Q4 25
$107.6M
$397.7M
Q3 25
$111.3M
$343.5M
Q2 25
$104.8M
$357.1M
Q1 25
$123.4M
$333.8M
Q4 24
$122.4M
$338.7M
Q3 24
$101.3M
$289.3M
Q2 24
$92.9M
$286.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTMD
BTMD
OSPN
OSPN
Operating Cash FlowLast quarter
$7.6M
$28.2M
Free Cash FlowOCF − Capex
$6.5M
FCF MarginFCF / Revenue
14.0%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
3.87×
2.44×
TTM Free Cash FlowTrailing 4 quarters
$30.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTMD
BTMD
OSPN
OSPN
Q1 26
$28.2M
Q4 25
$7.6M
$12.6M
Q3 25
$14.1M
$11.3M
Q2 25
$7.1M
$6.2M
Q1 25
$6.5M
$29.4M
Q4 24
$12.4M
$12.4M
Q3 24
$15.6M
$14.0M
Q2 24
$9.9M
$2.3M
Free Cash Flow
BTMD
BTMD
OSPN
OSPN
Q1 26
Q4 25
$6.5M
$9.6M
Q3 25
$13.6M
$8.8M
Q2 25
$5.3M
$4.4M
Q1 25
$4.8M
$27.7M
Q4 24
$10.7M
$10.5M
Q3 24
$14.0M
$12.0M
Q2 24
$7.4M
$26.0K
FCF Margin
BTMD
BTMD
OSPN
OSPN
Q1 26
Q4 25
14.0%
15.3%
Q3 25
28.3%
15.4%
Q2 25
10.8%
7.3%
Q1 25
9.9%
43.8%
Q4 24
21.5%
17.1%
Q3 24
27.3%
21.4%
Q2 24
15.1%
0.0%
Capex Intensity
BTMD
BTMD
OSPN
OSPN
Q1 26
Q4 25
2.3%
4.7%
Q3 25
1.0%
4.4%
Q2 25
3.7%
3.1%
Q1 25
3.3%
2.6%
Q4 24
3.4%
3.2%
Q3 24
3.0%
3.5%
Q2 24
5.1%
3.7%
Cash Conversion
BTMD
BTMD
OSPN
OSPN
Q1 26
2.44×
Q4 25
3.87×
0.29×
Q3 25
1.72×
1.74×
Q2 25
2.22×
0.75×
Q1 25
0.47×
2.02×
Q4 24
3.34×
0.43×
Q3 24
1.45×
1.69×
Q2 24
0.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTMD
BTMD

Product Revenue$45.3M98%
Disposable Trocars Product Revenue$1.2M3%

OSPN
OSPN

Product and license$35.5M54%
Services and other$30.4M46%

Related Comparisons